Westco Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Westco Advisory Services's VRTX Position: Q2 2026 in Review
Westco Advisory Services reduced its Vertex Pharmaceuticals (VRTX) stake by 2.5% in Q2 2026, selling an estimated $23K and leaving 1,997 shares worth $992K. The position accounts for 0.6% of the portfolio, ranked #33.
Westco Advisory Services first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. 1,743 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Westco Advisory Services held 1,997 shares of Vertex Pharmaceuticals worth $992K as of Q2 2026.
- Westco Advisory Services sold 52 Vertex Pharmaceuticals shares in Q2 2026, an estimated $23K.
- Vertex Pharmaceuticals made up 0.6% of Westco Advisory Services's portfolio in Q2 2026, its #33 holding.
- Westco Advisory Services first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 1,743 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Westco Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.